The COVID-19 pandemic, its impact on Mental Health and Substance Use Summary
DOI:
https://doi.org/10.5377/hcs.v0i16.10492Keywords:
COVID-19, Mental Health, Substance UseAbstract
COVID-19 is a highly contagious infectious respiratory disease that spreads rapidly from person to person through secretions and close contacts, quickly becoming a pandemic. In many countries various preventive measures such as quarantine and social distancing have been taken for a long time. This situation can have short and long-term consequences on people's mental health, as it is a source of prolonged stress, it can increase the risk of presenting mental health problems such as anxiety, depression, post-traumatic stress and risk behaviors such as increased substances use such as alcohol, tobacco, sedatives and other drugs during the course of the pandemic, as possible coping strategies in the face of stress. Despite the fact that various investigations have been carried out on COVID-19 and the mental health of the population, there is still very little information on the relationship between the pandemic and substance use, in the current circumstances and in the future. It is necessary to systematically study the relationship between the COVID-19 pandemic and substance use and abuse through longitudinal research designs.
Downloads
References
Asociación Americana de Psiquiatría, Manual diagnóstico y estadístico de los trastornos mentales (DSM-5®), 5a Ed. Arlington, VA, Asociación Americana de Psiquiatría, 2014.
Becoña, E., Cortes, M., Arias, F., Barreiro, C., Berdullas, J., Iraurgui, I., y López, A. (2011). Manual de adicciones para psicólogos especialistas en psicología clínica en formación. Barcelona: Socidrogalcohol.
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet, 395(10227), 912920. https://doi. org/10.1016/S0140-6736(20)30460-8
Bueno-Notivol, J., Gracia-García, P., Olaya, B., Lasheras, I., López-Antón, R. & Santabárbara, J. (2020). Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies. International Journal of Clinical and Health Psychology. https://doi.org/10.1016/j.ijchp.2020.07.007.
Caballo, V. E., Salazar, I. C. & Carrobles, J. A. (2014) (dirs.) Manual de psicopatología y trastornos psicológicos (2ª ed.). Madrid: Pirámide.
Guo, Y., Cao, Q., Hong, Z., Tan Y., Chen, S. & Jin, H. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak an update on the status. Military Medical Research, 7, 11. https://doi.org/10.1186/s40779-020-00240-0.
Huang, Y., & Zhao, N. (2020). Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry research, 288, 112954. https://doi.org/10.1016/j.psychres.2020.112954
Inchausti, F., MacBeth, A., Hasson-Ohayon, I., & Dimaggio, G. (2020). Psychological Intervention and COVID-19: What we know so far and what we can do. Journal of contemporary psychotherapy, 18. Advance online publication. https://doi.org/10.1007/s10879-020-09460-w.
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine. https://doi.org/10.1056/ NEJMo a2001 316.
Maguiña , C., Gastelo , R., & Tequen , A. (2020). El nuevo Coronavirus y la pandemia del Covid-19. Revista Médica Herediana, 31(2), 125-131. https://dx.doi.org/10.20453/rmh.v31i2.3776
McKay, D., & Asmundson, G. (2020). COVID-19 stress and substance use: Current issues and future preparations. Journal of anxiety disorders, 74, 102274. https://doi.org/10.1016/j.janxdis.2020.102274.
Oficina de las Naciones Unidas Contra la Droga y el Delito (ONUDD). (2017). Normas Internacionales para el Tratamiento de Trastornos por el Uso de Drogas. Ginebra: UNUDD.
Organización Mundial de la Salud (OMS). (1992). Clasificación Internacional de las Enfermedades (CIE-10). Trastornos mentales y del comportamiento. Ginebra: OMS.
Ornell, F., Schuch, J., Sordi, A. & Kessler F. (2020). Pandemic fear and COVID-19: mental health burden and strategies. Braz J Psychiatry, 42. 232-235. http://dx.doi.org/10.1590/1516-4446-2020-0008.
Ren, X., Huang, W., Pan, H., Huang, T., Wang, X., & Ma, Y. (2020). Mental Health During the Covid-19 Outbreak in China: a Meta-Analysis. The Psychiatric quarterly, 113. Advance online publication. https://doi. org/10.1007/s11126-020-09796-5
Salari, N., Hosseinian-Far, A., Jalali, R. et al. (2020). Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health, 16, 57. https://doi.org/10.1186/s12992-020-00589-w
Shanahan, L., Steinhoff, A., Bechtiger, L., Murray, A. L., Nivette, A., Hepp, U., Ribeaud, D., & Eisner, M. (2020). Emotional distress in young adults during the COVID-19 pandemic: evidence of risk and resilience from a longitudinal cohort study. Psychological medicine, 110. Advance online publication. https//doi. org/10.1017/S003329172000241X.
Shigemura, J., Ursano, R. J., Morganstein, J. C., Kurosawa, M., & Benedek, D. M. (2020). Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations. Psychiatry and Clinical Neurosciences, 74(4), 281282. https://doi.org/10.1111/pcn.12988.
Spagnolo, P. A., Montemitro, C., & Leggio, L. (2020). New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm. The American journal of psychiatry, 177(9), 805807. https://doi.org/10.1176/appi.ajp.2020.20040417
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., et al. (2020). Estimates of the severity of COVID-19 disease. MedRxiv. https://doi.org/10.1101/2020.03.09.20033 357.
Wei, Y. & Shah, R. (2020). Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications. Pharmaceuticals, 13(7), 155. https://doi.org/10.3390/ph13070155.
World Health Organization (WHO). (2020). Solidarity clinical trial for COVID-19 treatments. Ginebra: WHO. Recuperado de: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/glob
Xiong, J., Lipsitz, O., Nasri, F., Lui, L., Gill, H., Phan, L., Chen-Li, D., Iacobucci, M., Ho, R., Majeed, A., & McIntyre, R. S. (2020). Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of affective disorders, 277, 5564. Advance online publication. https://doi. org/10.1016/j.jad.2020.08.001
